Enjoy FREE shipping on your first order! (Minimum $99 purchase)
Enjoy FREE shipping on your first order! (Minimum $99 purchase)
When it comes to managing heart failure, finding the right treatment can make all the difference. Entresto, a prescription medication, is one of the newer therapies that has been proven to significantly improve outcomes for those living with heart failure. In this blog, we’ll dive into what Entresto really is. What is Entresto used for: how does it work, and the key benefits it offers to people with heart conditions?
Entresto is a combination medication that contains Sacubitril and Valsartan. It's primarily used to treat heart failure with reduced ejection fraction (HFrEF), a condition where the heart is unable to pump blood effectively. By targeting multiple systems within the body, Entresto helps improve heart function, reduce symptoms, and even save lives. Entresto is used for treating heart failure with reduced ejection fraction (HFrEF) and improving heart function, helping to reduce the risk of hospitalization and death associated with heart failure.
At the moment, it is exclusively offered as a name-brand drug. Entresto Generic has been approved by the FDA. However, it is unlikely to deploy until at least 2025, given the expiration date of Entresto's patent.
The combination of Sacubitril and Valsartan is the active ingredient in the medication Entresto, which is used to treat heart failure. Each component in this combination serves a distinct purpose in helping manage heart failure symptoms and improve overall heart function.
Here's a breakdown of each component:
Mechanism of Action: Sacubitril is a Neprilysin inhibitor. Neprilysin is an enzyme that breaks down certain beneficial substances in the body, such as natriuretic peptides, which help lower blood pressure and reduce fluid build-up. By inhibiting Neprilysin, Sacubitril increases the levels of these peptides.
Mechanism of Action: Valsartan is an angiotensin II receptor blocker (ARB). Angiotensin II is a hormone that causes blood vessels to constrict, which can increase blood pressure and the workload on the heart. Valsartan works by blocking the receptors for angiotensin II, preventing it from causing blood vessel constriction.
How the Combination Works Together:
By combining Sacubitril and Valsartan, Entresto has a synergistic effect in treating heart failure. Here's how the combination benefits patients:
Improved Blood Flow: Both Sacubitril and valsartan work to reduce blood pressure. Sacubitril enhances the action of substances that relax blood vessels, while valsartan blocks the constricting effects of angiotensin II.
Reduced Fluid Build-up: Sacubitril increases natriuretic peptides, which help reduce fluid retention, while valsartan prevents further stress on the heart, improving its ability to pump efficiently.
Enhanced Heart Function: Together, they work to improve the heart’s ability to pump blood, reducing the symptoms of heart failure such as fatigue, shortness of breath, and swelling.
Why This Combination Is Effective:
The combination of these two drugs, each targeting different aspects of heart failure, allows for a more comprehensive approach to managing the condition. Entresto has been shown to significantly reduce the risk of hospitalization and death from heart failure-related complications compared to traditional heart failure treatments, such as ACE inhibitors or ARBs alone.
In summary, the Sacubitril-Valsartan combination in Entresto helps reduce blood pressure, manage fluid build-up, and improve heart function, making it a highly effective treatment for people with heart failure.
How Entresto improve Heart Function?
Entresto improves heart function primarily through its combination of sacubitril and valsartan, which work together to reduce the workload on the heart, enhance blood flow, and manage fluid retention. Here’s a detailed breakdown of how these actions contribute to improved heart function:
Sacubitril is a Neprilysin inhibitor, which means it blocks an enzyme called Neprilysin. Neprilysin normally breaks down beneficial substances in the body, such as natriuretic peptides. These peptides have several protective effects on the heart and cardiovascular system. By inhibiting Neprilysin, sacubitril increases the levels of these peptides, which leads to the following benefits:
The increased levels of natriuretic peptides help dilate (relax) the blood vessels, reducing the resistance the heart has to work against when pumping blood. This lowers blood pressure and decreases the strain on the heart.
For a heart already weakened by heart failure, reducing the pressure in the blood vessels allows it to pump more efficiently and reduces the risk of damage to the heart muscle.
Natriuretic peptides also promote the elimination of excess sodium and water through the kidneys, which reduces fluid buildup in the body. Fluid retention is a common problem in heart failure, leading to symptoms such as swelling (edema) and shortness of breath.
By helping the body get rid of this excess fluid, sacubitril prevents the heart from being overworked by the need to pump excess blood and fluid.
By relieving fluid overload and reducing blood pressure, sacubitril helps improve the efficiency of the heart, allowing it to pump blood more effectively, which is crucial for patients with heart failure.
Valsartan is an angiotensin II receptor blocker (ARB). Angiotensin II is a hormone that constricts blood vessels, raising blood pressure and increasing the workload on the heart. When valsartan blocks the action of angiotensin II, it provides several key benefits:
Valsartan prevents the constriction of blood vessels, which reduces blood pressure. Lower blood pressure is essential for heart failure patients, as high blood pressure forces the heart to work harder and can exacerbate heart failure symptoms.
By relaxing blood vessels, valsartan reduces the resistance the heart faces when pumping blood, allowing the heart to work more easily. This is crucial for heart failure patients whose hearts may already be weakened and unable to pump blood effectively.
Over time, chronic heart failure can lead to heart remodelling, where the heart muscle becomes enlarged or thickened, which can worsen the condition. Valsartan helps to prevent or slow this remodelling process, thus preserving the heart’s ability to pump effectively over the long term.
When used together, sacubitril and valsartan have a synergistic effect, meaning they enhance each other’s beneficial actions, leading to a greater overall improvement in heart function:
Improved Blood Flow: The combination of sacubitril’s ability to dilate blood vessels and valsartan’s ability to block angiotensin II’s constriction effects leads to a significant reduction in blood pressure and an improvement in circulation. This reduces the strain on the heart and helps it pump more efficiently.
Reduced Fluid Build-up: Sacubitril helps reduce fluid retention, while valsartan reduces the strain that leads to fluid build-up, allowing the heart to focus on pumping blood rather than managing excess fluid.
Increased Exercise Tolerance: As fluid retention is managed and blood pressure is controlled, patients often experience less shortness of breath and fatigue, allowing them to engage in daily activities and exercise with more ease.
In the long run, Entresto helps slow the progression of heart failure by:
Improving Survival Rates: Studies have shown that Entresto significantly reduces the risk of death from heart-related causes in people with heart failure.
Reducing Hospitalizations: By managing symptoms like fluid buildup, shortness of breath, and swelling, Entresto lowers the risk of hospitalization for heart failure-related complications.
Improving Quality of Life: Patients often report feeling better, with less fatigue and more energy, which translates to a better quality of life.
The dosage of Entresto will depend on several factors, including your current heart failure treatment, kidney function, and how well you tolerate the medication. Here are the general guidelines:
For patients not currently taking an ACE inhibitor or ARB: The typical starting dose is 49/51 mg twice daily (49 mg of sacubitril and 51 mg of valsartan). This lower dose helps the body adjust to the medication and reduces the risk of side effects.
For patients switching from an ACE inhibitor or ARB: If you’re already taking an ACE inhibitor or ARB and your heart failure is not well controlled, your doctor may switch you to Entresto. Typically, the starting dose for patients who were previously on an ACE inhibitor or ARB is 24/26 mg twice daily to minimize the risk of low blood pressure (hypotension) or other reactions.
Dose Titration: After about two to four weeks, your doctor may increase the dose of Entresto based on how well you tolerate it and the improvement in your symptoms.
Standard maintenance dose: 97/103 mg twice daily (97 mg sacubitril and 103 mg valsartan).
Maximum Dose: The maximum dose is typically 97/103 mg twice daily for most patients, but your doctor will determine the appropriate dose for you based on your individual response to the medication.
Kidney Function: If you have kidney problems, your doctor may adjust your dosage or monitor your kidney function more closely while you’re taking Entresto.
Elderly Patients: Older adults may need a lower starting dose to minimize side effects.
Liver Problems: If you have liver problems, the dosage may need to be reduced, and your doctor will monitor your liver function during treatment.
As with all medications, Entresto may cause side effects, though not everyone will experience them. Understanding and managing these side effects is key to maximizing the benefits of the medication.
Symptoms: Dizziness, light-headedness, fainting.
Management: To minimize the risk of low blood pressure, it’s important to start at a lower dose and gradually increase it. Also, make sure to stay hydrated and rise slowly from a sitting or lying position. If symptoms of low blood pressure persist, contact your doctor for a dose adjustment.
Symptoms: Muscle weakness, irregular heartbeat, fatigue.
Management: Your doctor will regularly check your potassium levels, especially during the first few months of treatment. Avoid potassium supplements or salt substitutes unless approved by your doctor.
Symptoms: Decreased urine output, and swelling in the legs or ankles.
Management: Entresto can affect kidney function, so your doctor will monitor your kidney function through blood tests. If kidney issues are detected, your doctor may adjust the dose or switch medications.
Symptoms: Persistent cough.
Management: A cough is less common with Entresto compared to ACE inhibitors, but it may still occur in some patients. If a cough becomes bothersome, consult your doctor to discuss alternatives.
Symptoms: A sensation of spinning or fainting.
Management: To prevent dizziness, avoid standing up too quickly, and drink plenty of fluids. If dizziness is severe, consult your doctor for possible dosage adjustments.
The cost of Entresto can vary depending on factors such as location, dosage, pharmacy, and whether you have insurance coverage. On average, Entresto can cost between $450 to $1,200 per month without insurance, depending on the prescribed dose and the number of tablets you need.
When considering buying Entresto online, it's essential to ensure you’re purchasing from a reputable, licensed pharmacy. Trusted online platforms such as Canada Pharmacy Pro offer the convenience of ordering your prescription medication from home, often with competitive pricing and delivery options. Before buying, make sure you have a valid prescription from your healthcare provider, as Entresto is a prescription-only medication. Additionally, many online pharmacies provide discounts, coupons, or patient assistance programs to help reduce the cost of Entresto, making it more affordable. Always be cautious of unverified sellers to avoid counterfeit medications and ensure the quality and safety of the product you’re purchasing.
Entresto is a ground-breaking medication that works by addressing two crucial mechanisms in the body that affect heart health: blood pressure regulation and fluid balance. With its dual-action formula, it improves heart function, reduces the risk of hospitalization, and can even improve quality of life for those with heart failure. If you're living with heart failure, talk to your doctor about how Entresto might help protect your heart and improve your health.
By understanding how Entresto works, you can feel more confident in managing your heart health and taking proactive steps toward a better future.
Entresto is different from other heart failure medications due to its unique combination of two active ingredients: sacubitril and valsartan. Unlike traditional heart failure treatments, such as ACE inhibitors or beta-blockers, Entresto works on multiple fronts. This dual-action approach allows Entresto to more effectively improve heart function, reduce the risk of hospitalization due to heart failure, and improve survival rates compared to conventional medications.
Entresto (sacubitril/valsartan) should not be taken with certain medications due to potential harmful interactions. Angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril or enalapril, are contraindicated as they increase the risk of angioedema. Potassium-sparing diuretics (e.g., spironolactone), potassium supplements, or salt substitutes can lead to hyperkalemia (high potassium levels). Nonsteroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, may reduce kidney function when combined with Entresto. Additionally, using it with aliskiren, a direct renin inhibitor, is not recommended in patients with diabetes or kidney impairment. Always consult your doctor before starting or stopping any medication with Entresto.
The effects of Entresto can be observed within a few weeks of starting treatment, although it may take several months to experience the full benefits. In clinical studies, patients with heart failure typically notice improvements in symptoms such as reduced shortness of breath, less fluid retention, and increased exercise tolerance within 1 to 2 weeks. However, the long-term benefits, such as a reduction in hospitalizations due to heart failure and improved survival rates, are more evident after 2 to 3 months of consistent use.
While taking Entresto, it’s important to follow certain precautions to ensure the medication is effective and to minimize the risk of side effects. First, monitor your blood pressure regularly, as Entresto can lower blood pressure, and it’s essential to avoid it dropping too low. If you feel lightheaded or dizzy, rise slowly from a seated or lying position. Kidney function should also be regularly monitored, as Entresto can affect kidney health. Your doctor may conduct blood tests to check kidney function and potassium levels, as high potassium can be a concern.
> Genvoya Cost in the USA: Savings and Coverage
> Summer Migraine Management: Triggers & Relief
> Starting Genvoya: What to Expect and How It Treats HIV-1
